institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Low-Income Pennsylvanians Could Lose Access to Weight-Loss Drugs as Harrisburg Searches for Savings

  • Pennsylvania plans to end coverage of GLP-1 weight-loss drugs under Senate benefits starting July 1, 2025, amid rising costs.
  • This move follows rapidly increasing expenditures on GLP-1s, with $222 million spent in 2022 and $650 million to cover 70,000 recipients in 2024.
  • The Shapiro administration plans to limit Medicaid coverage of weight-loss medications to individuals who meet specific BMI thresholds or have certain long-term health issues, such as hypertension or cardiovascular disease, that necessitate weight reduction.
  • State Rep. Arvind Venkat criticized the restrictions saying they will force patients to suffer serious medical harm before qualifying, and he introduced a bipartisan bill for price negotiation with manufacturers.
  • Lawmakers differ on solutions, with Senate Republicans supporting cuts while some House members favor proactive obesity treatment and negotiating lower drug prices to maintain access.
Insights by Ground AI
Does this summary seem wrong?

11 Articles

All
Left
1
Center
3
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

newsweek.pl broke the news in on Thursday, June 12, 2025.
Sources are mostly out of (0)